false
Catalog
Understanding Comorbid Substance Use Disorders and ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a summary of a presentation on understanding comorbid substance use disorders (SUDs) and serious mental illness (SMI). The presentation was part of an initiative by the American Psychiatric Association (APA) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The presentation covered topics such as prevalence rates of SUDs, the definition of addiction, diagnostic criteria for SUDs, screening for risky substance use, and pharmaceutical treatment options for alcohol use disorder and opioid use disorder.<br /><br />The prevalence of SUDs in the United States is significant, but very few individuals with a SUD receive treatment. Motivational interviewing (MI) was discussed as a useful approach to improving change talk and behaviors in individuals with SUDs. Medication-assisted treatment (MAT) was identified as a first-line treatment option for individuals with SMI and SUDs. The medications acamprosate and disulfiram were discussed as treatment options for alcohol use disorder, while methadone, buprenorphine, and naltrexone were discussed as treatment options for opioid use disorder.<br /><br />The presentation emphasized the importance of comprehensive care and the role of healthcare providers in treating SUDs. Referral to substance use/mental health specialty services was recommended for individuals who screen positive for a substance use related issue. The presentation also highlighted the need for a person-centered approach and the importance of language in reducing stigma around SUDs.<br /><br />Overall, the presentation provided valuable information on the prevalence, diagnosis, and treatment of comorbid SUDs and SMI, as well as practical tools and resources for healthcare providers.
Keywords
Comorbid substance use disorders
Serious mental illness
American Psychiatric Association
Substance Abuse and Mental Health Services Administration
Prevalence rates of SUDs
Addiction definition
Diagnostic criteria for SUDs
Screening for risky substance use
Pharmaceutical treatment options
Motivational interviewing
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English